Attendee Demographics
View the demographics from previous Annual Meetings.
|
Professionals:
|
25,500
|
|
Exhibitors:
|
4200
|
|
Spouse, Guest, Media:
|
1550 |
|
Domestic Attendees:
|
48%
|
|
International Attendees:
|
52%
|
| |
|
|
USA
|
12,153
|
|
Germany
|
1373
|
|
Japan
|
1312
|
|
France
|
1012
|
|
Canada
|
815
|
|
United Kingdom
|
695
|
|
Brazil
|
680
|
|
Italy
|
600
|
|
China
|
561
|
|
Switzerland
|
513
|
|
107 Other Countries
|
6406
|
| Total Professional Attendees: |
25,500
|
| |
| Physician |
46% |
| Other |
33% |
| Researcher |
7% |
| Pharmacist |
2% |
| No Response |
2% |
| Biostatistician/Epidemiologist |
1% |
| Nurse |
1% |
| |
| |
| Medical Oncology |
24% |
| Internal Medicine |
16% |
| Not Applicable |
14% |
| Other |
13% |
| Hematology |
9% |
| Pharmacology (Clinical) |
2% |
| Laboratory Research |
2% |
| Surgery (including Surgical Oncology and Surgical Specialties) |
2% |
| Biostatistics/Epidemiology |
2% |
| Pediatrics (including Pediatric Oncology and Pediatric Specialties) |
2% |
| Radiation Oncology |
2% |
| Gynecologic Oncology |
2% |
| Allied Health (e.g., Psychology, Physical Therapy, Social Work, etc.) |
1% |
| Gastroenterology |
1% |
| Oncology Nursing |
1% |
| Urology/Urologic Oncology |
1% |
| |
| Breast Cancer |
25% |
| Clinical Trials |
22% |
| Lung Cancer |
19% |
| Gastrointestinal (Colorectal Cancer) |
15% |
| Developmental Therapeutics |
11% |
| Gastrointestinal (Noncolorectal Cancer) |
10% |
| Tumor Biology |
10% |
| Lymphoma and Plasma Cell Disorder |
9% |
| Cancer Genetics |
9% |
| Leukemia, Myelodysplasia, and Transplantation |
8% |
| Genitourinary Cancer |
8% |
| Other |
6% |
| Melanoma/Skin Cancer |
6% |
| Gynecologic Cancer |
6% |
| Head and Neck Cancer |
5% |
| Cancer Prevention/Epidemiology |
4% |
| Patient and Survivor Care |
4% |
| Sarcoma/Bone and Soft tissue Cancers |
4% |
| Professional Development |
4% |
| Health Services Research |
3% |
| Central Nervous System Tumors |
3% |
| Pediatric Cancer |
2% |
| Pathology |
2% |
| Practice Management and Information Technology |
2% |
| Ethics |
2% |
| Geriatric Oncology |
1% |